TransMedics holds consensus Hold with Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
TransMedics Group (NASDAQ:TMDX) carries a consensus "Hold" rating from brokerages, with an average 12-month price target of Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
TransMedics Group (NASDAQ:TMDX) carries a consensus "Hold" rating from brokerages, with an average 12-month price target of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context